Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accreted, aggressive, alleviated, Axel, Cervarix, Cervarix®were, cervical, consecutive, covenanted, daily, drawdown, dusquetide, Ebola, eighty, Excellence, Farmaceutiche, footnote, formula, Garcea, Hawaii, HBI, HPV, ideal, ImmunoCellular, imputed, indemnification, John, Journal, Kingsbrook, Kodiak, Lehrer, LP, Maria, Master, Onexeo, online, OrbeShield®and, OrbeShield®in, particle, prevailing, promissory, promulgated, proof, protocol, Randolph, Riunite, River, scalable, SECURITIESE, Seed, sophisticated, SPORE, Subtopic, ThermoVax®development, ThermoVax®indicate, ThermoVax®technology, transparency, trend, tumor, USA, vesicular, visit, VLP, weekly, whatsoever
Removed:
abthrax, adapt, Adsorbed, ago, Anthim, apparent, AVA, Bavarian, BioThrax, blocking, bloodstream, cancelled, cellular, collaborating, compatible, confirmatory, conformational, consultant, continuing, culture, cytoplasm, discontinued, DNI, dominant, dormant, double, DSMB, durable, Dynavax, efficiently, endosomal, enhancing, environmentally, Evan, exceptionally, expiring, extending, extension, fewest, filtrate, germinate, glassification, globulin, headcount, hope, Horgan, impede, inhalation, inhalational, intradermal, intramuscular, Kevin, lie, Medarex, membrane, mutant, neutralize, newer, Nordic, onset, optioned, orBec, overwhelming, Pfenex, plasma, point, potency, predetermined, Principally, processing, progressing, prompted, prophylactic, recommendation, Recording, reexamination, reissue, releasing, rPA, safer, shock, smallpox, step, stockpiled, stopped, substitution, synthesize, thereof, toxemia, trafficking, translocation, transmitted, transported, typical, ungerminated, unstable, vaccinate, Valortim, vegetative, velothrax™, vial
Filing tables
Filing exhibits
- 10-K Annual report
- 10.31 Purchase Agreement Dated As of March 22, 2016 Between the Company and Lincoln Park Capital Fund, LLC.
- 10.32 Registration Rights Agreement Dated As of March 22, 2016 Between the Company and Lincoln Park Capital Fund, LLC.
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Eisneramper LLP.
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
SNGX similar filings
Filing view
External links